Clinical trial
A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine…
NCT00402584 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00402584 |
|---|---|
| Title | A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder |
| Official title | A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Examine the Efficacy and Safety of Meridia (Sibutramine Hydrochloride) in Binge-Eating Disorder |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Binge Eating Disorder, Obesity |
| Intervention type | Drug |
| Interventions | sibutramine |
| Enrollment | 304 |
| Start date | Aug 1, 2000 |
| First posted | Nov 22, 2006 |
| Last update posted | Aug 31, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: